FDA approves OZURDEX implant for uveitis treatment

Links shared publicly online about this topic.

  • 843
    total visits

FDA approves OZURDEX implant for uveitis treatment

news-medical.net

Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.

View full resource at news-medical.net

Tags: Ulcerative Colitis Medication, Obesity, Diet and Nutrition, Drug, FDA, Allergan, News

  • Share

Most Recently Shared on September 27, 2010 at 8:13 am By:

Obesity_News News-Medical.Net

Obesity News: FDA approves OZURDEX implant for uveitis treatment: Allergan, Inc. today announced that the United S... http://bit.ly/9kS2e6

2 years ago...

Ozurdex approved for non-infectious uveitis - ONA

oncologynurseadvisor.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on September 28, 2010 at 6:07 pm By:

Ozurdex approved for non-infectious uveitis - MPR

empr.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 28, 2010 at 5:20 pm By:

eMPR MPR Medical Publisher

MPR News: Ozurdex approved for non-infectious uveitis: The FDA has approved Ozurdex (dexamethasone intravitreal im... http://bit.ly/9QhxHZ

2 years ago...

Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

agn.client.shareholder.com — “Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the EyeView full resource at agn.client.shareholder.com

  • View Related
  • Share

Most Recently Shared on September 24, 2010 at 8:37 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Allergan Gets FDA OK 4 OZURDEX(R) - Trtmnt Option 4 Non-Infectious Uveitis Affecting Posterior Segment of the Eye http://ow.ly/2JA4J

2 years ago...

Ozurdex Implant Likely to Help Diabetic Macular Edema

retinaeyedoctor.com — “Easy AdSense by Unreal There is a new implant available to us in the United States for treatment of macular swelling (edema). The implant, Ozurdex, is a product of Allergan Pharmaceuticals and received FDA approval in June 2009 for treatmentView full resource at retinaeyedoctor.com

  • View Related
  • Share

Most Recently Shared on September 8, 2009 at 12:30 pm By:

retinadoc Randall Wong, MD Doctor, Surgeon, Ophthalmologist, and Physician

Ozurdex (steroid implant) likely to help diabetic macular edema. http://bit.ly/44ObOQ

3 years ago...

Advertisement